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Abstract 
Technical data on local CT practice in Western Australia were collected for five major CT providers 
using a self-completed questionnaire. The CTDIvol DLP and effective dose for each protocol were 
obtained and providers were ranked according to radiation burden for each clinical scenario. The 
mean, median, 75th percentile and standard deviation were calculated for both effective dose and DLP 
for each scenario and these values compared with published data. CT utilisation data were used to 
estimate the attributable radiation dose to the WA population and the potential change in population 
annual effective dose according to protocol used was estimated. We found wide variations in 
technique and radiation dose exist across providers for similar examinations producing a higher 
radiation burden than reported internationally.  As expected the CT protocol used dramatically affects 
the radiation dose received and this has a significant effect on annual population doses. The study 
highlights the need for recognition and understanding of both the degree of variation in radiation dose 
across providers and the relatively high radiation burden afforded by protocols in use in Western 
Australia so necessary dialogue can be launched for practitioner consensus of appropriate diagnostic 






One of the most potent factors driving innovations in medicine has been technological advances in 
diagnostic imaging 
1
.  Despite the benefits that these innovations have brought, concerns have been 
expressed about the escalating cost of unrestrained use of medical imaging.  Introduction of helical 
(spiral) Computed Tomography (CT) scanning resulted in large increases in examinations performed 
and average ‘scanned patient volume’ per examination
2
.  In the United States it was estimated that the 






During its infancy while CT was recognised as a relatively high radiation dose procedure there was 
appreciable clinical justification for using it.  Initially no other modality could compete with CT on 
the diagnostic accuracy of brain scans; and when CT of the rest of the body first began, its use was 
largely limited to cancer patients where radiation dose presented lesser risks
4
.  However, the 
circumstances of CT use are now very different
5
.  Today CT is used extensively in benign disease and 
young patients, for whom radiation protection considerations hold greater weight
4
.  Some countries 
have attempted to reduce the population radiation dose from medical imaging procedures through 
guidelines, advising on clinical indications for utilisation and / or reference levels for the radiation 
dose received from each type of examination
6,7
.  To date while Australia has developed some clinical 
guidelines it has not implemented diagnostic reference levels despite the potential for dose reductions 
of up to 30%
8
. 
The only study, apart from that performed by UNSCEAR (which included limited Australian data)
9
, 
to assess CT utilisation and dosimetry in Australia was a survey in 1996 of all CT facilities conducted 
by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA), formerly the 
Australian Radiation Laboratory
10
. This study found Australia had the second highest provision of CT 
scanners per capita with triple the number of CT scanners per capita compared with the UK or New 
Zealand and a slightly higher provision than the US. Australia recorded just over 60 examinations per 
1,000 people, a level of utilisation three times that of the UK and New Zealand rates and similar to the 
US.  Of most concern was the mean dose per examination from CT in Australia was between 50% and 
69% higher than observed in any other country (6.6mSv compared with 4.4mSv in Japan and New 
Zealand and 3.9mSv in the UK).  The authors attributed the larger dose per examination to a higher 
average number of scans (slices) per examination in Australia. The high dose per examination 
combined with the large number of examinations performed equated to a mean effective dose per 
capita in Australia five times greater than in New Zealand and seven times  the UK
10
.  In 2011 an 
OECD report
11
 again documented that Australia had the second highest provision of CT scanners per 
capita; however, utilisation was below the OECD average at 94 per 1,000 population (OECD average 
132 per 1,000) ranking well below the US (228 per 1,000) but still above the UK (73 per 1,000). It 
should be noted that these figures exclude examinations undertaken on in-patients in Australian public 
hospitals and therefore are not comprehensive. 
Practice guidelines are limited and not universally agreed upon in Australia, not only in regard to the 
indication of use for specific diagnostic radiology procedures, but also on how to conduct a particular 
procedure to provide sufficient diagnostic quality with the least radiation burden.  Currently, for any 
single clinical indication, a multitude of different protocols are used without consensus. An important 
reason for this situation is a lack of recent relevant local evidence as the substrate from which 
consensus can be achieved. 
The purpose of this study was to (i) determine the range of radiation dose attributable to differences in 
CT protocols reported by a sample of providers in Western Australia (WA) for a range of CT scans 
undertaken commonly on adults; ii) determine how the radiation burden of these protocols compares 
with similar published surveys and national diagnostic reference levels; and (iii) determine the effect 
on the annual population cumulative effective radiation dose between 2005 and 2010 produced by 




2.1. Data collection 
Technical data on local CT practice in Western Australia were collected for five major CT providers 
by means of a questionnaire that was self-completed and followed up by interviewing the respondents 
to clarify and validate the information provided. The questionnaire was that used by the national 
survey of doses from CT in the UK in 2003
12
 and was amended only in terms of the clinical scenarios 
examined (addition of chest for pulmonary embolus) and was limited to examinations performed on 
adults. The questionnaire sought scanning data in relation to standard protocols for seven common CT 
examinations shown below performed on standard (average-sized) patients to represent “usual 
practice”. 
1. Routine Head for trauma or stroke 
2. Chest for lung cancer (known or suspected metastases) 
3. Chest for pulmonary embolism 
4. High resolution Chest for diffuse lung disease 
5. Abdomen for liver metastases (upper abdomen for abscess) 
6. Abdomen / Pelvis (unspecified clinical indication) 
7. Chest/Abdomen /Pelvis for lymphoma staging 
The seven clinical scenarios were chosen after liaison with clinicians to provide an overview of 
protocols (i) used frequently in the clinical setting for adult patients, (ii) provide a range of scenarios 
covering a range of anatomic locations involving radiosensitive organs and (iii) facilitate comparison 
with published protocols and diagnostic reference levels. Specific clinical indications were included 
for all types of CT examination since these could influence the scanning technique used. This 
approach was intended to make the data from different CT centres more comparable.  
Protocol information (excluding the scout view) consisting of separate scanning sequences where 
appropriate, each representing a single helical exposure or a series of similar axial exposures using 
identical scan conditions was collected for each provider. Only those sequences performed routinely 
for most patients were included in the data analysis. The data collected included various technical 
parameters such as kilovoltage (kV), milliamperage (mA), tube rotation times, collimation widths, 
pitch, scanning method, typical anatomical reference start-stop positions of the scan. Respondents 
were asked to report the average volume weighted CT dose index (CTDIvol) and dose–length product 
(DLP) based on up to ten standard (average-sized) adult patients undergoing each protocol. 
The providers surveyed included one tertiary metropolitan public hospital, two private metropolitan 
hospitals, one secondary public hospital whose radiology services were provided onsite by a private 
radiology group, and one rural hospital whose radiology services were provided onsite by a private 
radiology group.  
 
2.2. Radiation dosimetry 
Dosimetry involved reporting of values of CTDIvol, DLP and calculation of effective dose for each 
sequence accomplished on the basis of the scan settings provided in the questionnaires and the 
representative scanner-specific dosimetrics published by ImPACT as part of its CT patient dosimetry 
calculator
13 based on International Commission on Radiological Protection (ICRP) 10314 tissue 
weighting factors. Either average tube current (with automatic modulation) or current-time products 
(without automatic modulation) were used as reported by each site. DLPs for each sequence were 
reported in the questionnaire. Effective doses were derived by obtaining scan length by dividing DLP 
by CTDIvol, then using this and other reported parameters in the ImPACT dose calculator.  It was 
found that ImPACT frequently gave somewhat different values of CTDIvol to those reported so the 
effective dose given by ImPACT was corrected by the ratio of reported CTDIvol and that given by 
ImPACT. Protocol (cumulative) values of DLP and effective dose were also calculated on the basis of 
summation over all routine sequences reported for each standard protocol. Incomplete or inconsistent 
data provided in questionnaires were discussed at a follow up interview with providers. 
Providers were ranked according to the protocol effective dose for each clinical scenario and the 
lowest, median and highest dose values for each protocol were identified together with the maximum / 
minimum ratio for each scenario. In addition the mean, median, 75
th
 percentile and standard deviation 
was calculated for both effective dose and DLP for each scenario. These values were compared with 
published data for both DLP and effective dose. 
  
2.3. CT Scans and WA Adult Population 
The numbers of CT scans performed in Western Australia on adults by gender and age were identified 
using (i) Hospital Morbidity data (HMDS) for hospitalised patients (2005-2010) and (ii) Medicare 
Benefits Schedule data (MBS) for out-of-hospital procedures (1999-2010). Published MBS data were 
also used to determine the total number of medical imaging and CT scanning investigations 
performed in each Australian State. When the CT examination was not used exclusively for the 
clinical scenario detailed in the survey the allocation of number of CT scans attributed to that scenario 
was obtained using a combination of the HMDS code (providing the examination performed) and 
diagnosis code. Since diagnosis codes were only available in the in-patient setting the relative 
frequencies observed for each examination / diagnosis combination were then used to estimate the 
number of CT scans performed for each clinical scenario in the out-of-hospital setting.  
 
2.4. Cumulative Population Dose 
The lowest, median and highest doses for each protocol were multiplied by the number of CT scans 
estimated to have been performed in each clinical scenario in the study in Western Australia and used 
to calculate the best, median and worst case cumulative annual population effective dose from 2005 to 
2010. The annual number of CT scans and effective dose attributed to each clinical scenario was then 




Table 1 shows a summary of the sequence related scanning parameters and dosimetry for the seven 
CT scanning clinical procedures evaluated. The scanning parameters and radiation dosimetry varied 
greatly across providers for the same clinical scenario. 
 
3.1. Examination technique CT scanning procedures: number of sequences 
Only two clinical settings (chest for lung cancer and abdomen/pelvis for abscess) provided 
concordance between all providers routinely undertaking the same number of sequences (one). The 
greatest discordance was observed in abdomen CT for liver metastases where three providers reported 
one sequence, one provider reported two sequences and one provider (D) reported four sequences 
routinely performed.  
Table 1 Scanning parameters and radiation dose for seven commonly performed CT scanning clinical procedures across 





















A Public 1 64 Slice Helical 120 338 0.423 86.70 1256 3.30 
B Private 1 64 Slice Helical 140 120 0.328 70.40 1021 2.40 
C Private 1 64 Slice Helical 135 220 0.328 129.20 1873 4.30 
D Private 1 Dual Slice Axial 135 150 1.000 99.40 1441 3.40 
E Private 1 16 Slice Axial 140 140 1.000 69.60 1009 2.40 
  
2 16 Slice Axial 120 110 1.000 37.60 545 1.30 





A Public 1 64 Slice Helical 120 402 1.078 26.60 1131 20.0 
B Private 1 64 Slice Helical 120 300 0.828 17.20 474 8.5 
C Private 1 64 Slice Helical 120 300 0.828 17.20 732 13.0 
D Private 1 Dual Slice Helical 120 350 1.500 34.00 934 16.0 




A Public 1 64 Slice Helical 120 498 0.673 35.20 968 17.0 
B Private 1 64 Slice Helical 120 300 0.828 13.80 379 6.8 
C Private 1 64 Slice Helical 120 300 0.828 17.20 474 8.5 
D Private 1 Dual Slice Axial 120 100 1.000 29.90 823 14.0 
 
 
2 Dual Slice Axial 120 350 1.000 27.90 768 13.0 






A Public 1 64 Slice Helical 140 369 0.516 38.10 1048 19.0 
B Private 1 64 Slice Helical 120 235 0.828 13.50 371 6.6 
  
2 64 Slice Helical 120 80 1.484 2.60 71 1.3 
C Private 1 64 Slice Helical 120 300 0.828 17.20 474 8.5 
  
2 64 Slice Axial 120 292 1.000 16.80 461 8.2 
D Private 1 Dual Slice Axial 140 160 1.000 23.60 649 11.0 





A Public 1 64 Slice Helical 120 309 0.891 24.70 1138 19.5 
B Private 1 64 Slice Helical 120 300 0.828 17.20 793 14.0 
  
2 64 Slice Helical 120 650 0.828 37.30 1717 30.0 
C Private 1 64 Slice Helical 120 302 0.828 17.30 798 14.0 
D Private 1 Dual Slice Helical 120 250 1.500 17.90 429 7.0 
  
2 Dual Slice Helical 120 350 1.500 25.00 600 9.7 
  
3 Dual Slice Helical 120 350 1.500 25.00 1150 19.5 
  
4 Dual Slice Helical 120 350 1.500 25.00 600 9.7 




A Public 1 64 Slice Helical 120 333 0.891 26.70 1226 21.5 
B Private 1 64 Slice Helical 120 300 0.828 17.20 793 14.0 
C Private 1 64 Slice Helical 120 302 0.828 17.30 798 14.0 
D Private 1 Dual Slice Helical 120 350 1.500 25.00 1150 19.5 







A Public 1 64 Slice Helical 120 431 1.078 24.80 1720 29.50 
B Private 1 64 Slice Helical 120 600 0.828 34.50 2395 41.50 
  
2 64 Slice Helical 120 660 0.828 37.90 2635 45.50 
C Private 1 64 Slice Helical 120 300 0.828 17.20 474 8.50 
  
2 64 Slice Helical 120 300 0.828 17.20 793 14.00 
D Private 1 Dual Slice Helical 120 300 1.500 21.40 589 10.00 
  
2 Dual Slice Helical 120 300 1.500 21.40 986 17.00 
E Private 1 16 Slice Helical 120 430 0.750 27.90 1936 34.00 
aSeq = sequence number (numbers over 1 indicate multiple scanning acquisitions within the same protocol).    
bCTDIvol = Volumetric CT Dose Index, measured in mGy.  
cDLP = Dose Length Product, measured in mGy.cm.         
dEffective Dose = mSv calculated using ImPACT for each sequence. 
 
3.2. Examination technique CT scanning procedures: kV, mA and pitch 
Two scenarios presented some variation between providers for kV. With respect to routine Head CT 
providers reported a range of kV settings ranging from 120 (three providers to 140 (two providers). 
Notably provider E reported using 140kV for the first sequence and 120kV for the remaining two 
sequences. Similarly for Chest for diffuse lung disease; while the most common setting was 120kV, 
two providers reported using 140kV.  
With respect to mA it was noted there was not always correlation between high kV and low mA 
which would be expected.  While pitch for all sequences is reported in the table, only pitch values for 
helical scans were evaluated for concordance. Pitch was quite variable in all clinical scenarios except 
Head CT which reported the smallest differences in pitch ranging from 0.33 to 0.42.  
 
3.3. Radiation dosimetry: protocols 
The cumulative radiation dosimetry in terms of DLP and effective dose calculated for each protocol is 
shown in table 2. This table also shows their ranking with respect to radiation burden, absolute and 
relative differences compared with the protocol generating the median radiation dose across providers 
in each scenario and the maximum/minimum ratio. The public provider ranked either highest or 
second highest in radiation burden in four of the seven clinical scenarios under examination and did 
not rank as lowest in any clinical scenario. When the ranking was averaged across all procedures the 
several private providers had a lower average rank than the public provider indicating that generally 
the public provider used protocols which gave higher radiation dose than the private providers.  
When evaluating differences between the maximum and minimum doses reported the largest ratios 
were observed in chest CT for pulmonary embolism and CT Chest/Abdo/Pelvis examinations where 
the max/min ratios were 4.0 and 3.9 respectively. This equated to an absolute difference of 18mSv for 
chest CT for pulmonary embolism and 58mSv for CT Chest/Abdo/Pelvis. The smallest maximum to 
minimum ratio was observed for CT of the abdomen/pelvis (1.6) and CT head (1.9) equating to 
absolute differences of 3.5mSv and 1.2mSv respectively. 
 
Table 2 Variation in radiation dose for seven commonly performed CT scanning protocols across five clinical sites in 
Western Australia 




























Head for Trauma 
or Stroke 
  
A Public 1256 3.30 2 -0.1 -2.9 
1.9 
B Private 1021 2.40 1 -1.0 -29.4 
C Private 1873 4.30 4 +0.9 +26.5 
D Private 1441 3.40 3 0.0 0.0 
E Private 1951 4.63 5 +1.2 +36.2 
Chest for Lung 
Cancer 
  
A Public 1131 20.00 4 +4.0 +25.0 
2.6 
B Private 474 8.50 1 -7.5 -46.9 
C Private 732 13.00 2 -3.0 -18.8 
D Private 934 16.00 3 0.0 0.00 





A Public 968 17.00 4 +8.1 +91.0 
4.0 
B Private 379 6.80 1 -2.1 -23.6 
C Private 474 8.50 2 -0.4 -4.5 
D Private 1591 27.00 5 +18.1 +203.4 
E Private 490 8.90 3 0.0 0.00 
Chest for Diffuse 
Lung Disease 
  
A Public 1048 19.00 5 +6.0 +46.2 
2.4 
B Private 442 7.90 1 -5.1 -39.2 
C Private 935 16.70 4 +3.7 +28.5 
D Private 649 11.00 2 -2.0 -15.4 




A Public 1138 19.50 2 -3.5 -15.2 
3.3 
B Private 2510 44.00 4 +21.0 +91.3 
C Private 798 14.00 1 -9.0 -39.1 
D Private 2779 45.75 5 +22.8 +98.9 
E Private 1297 23.00 3 0.00 0.0 
Abdomen and 
Pelvis for Abscess 
  
A Public 1226 21.50 4 +2.00 +10.3 
1.6 
B Private 793 14.00 1 -5.5 -28.2 
C Private 798 14.00 1 -5.5 -28.2 
D Private 1150 19.50 3 0.0 0.0 
E Private 1297 23.00 5 +3.5 +18.0 
Chest, Abdomen 




A Public 1720 29.50 3 0.0 0.0 
3.9 
B Private 5030 87.00 5 +57.5 +194.9 
C Private 1267 22.50 1 -7.0 -23.7 
D Private 1575 27.00 2 -2.5 -8.5 
E Private 1936 34.00 4 +4.5 +15.3 
 
aProtocol DLP = Sum of DLP values in protocol where multiple sequences included. 
bProtocol Effective Dose  = cumulative  effective dose over all sequences in protocol (excludes scout view). 
cRanked according to total radiation burden (DLP or effective dose) per protocol lowest (1) to highest (5). Protocol affording the median 
radiation burden = 3 (bold italic). 
dMax/min ratio based on protocol effective doses in clinical scenario across the five clinical sites. 
3.4. Comparison of DLP and effective dose values with published data 
Tables 3 and 4 show the mean, median, 75
th
 percentile, standard deviation, minimum and maximum 
DLP (table 3) and effective dose (table 4) values reported in the current study for the entire protocol 
for each of the seven clinical scenarios considered. It also shows a range of mean values reported in 
the literature obtained by similar self-complete surveys and four examples of national diagnostic 
reference levels (DRL’s) expressed in terms of DLP and effective dose. Our results indicate providers 
in Western Australia use higher dose (mean DLP and effective dose) protocols than those reported in 
the literature across all scenarios. The values reported for the 75
th
 percentile from our study (ie the 
standard method used to generate a national DRL) show that if these results were used WA would 
have DRL’s markedly higher than other countries. In the case of Abdominal CT the DRL would be 
almost three times greater than the upper range of the highest published DRL for that examination 
(DLP base DRL for Canada). 
Table 3 Comparison of DLP values for CT protocols performed in Western Australia for seven common clinical scenarios with published literature and international 
diagnostic reference levels 
Scan type/clinical scenario 






















 Protocol DLP  (mGy cm)
a
 
              










Chest for Pulmonary Emboli 780.4 490 1279.5 507.8 379 1591 327 - - - 280 - - - 
Chest for Diffuse Lung Disease 761.8 735 991.5 238.5 442 1048 327 - - - 900 - - - 








Chest, Abdomen and Pelvis for Lymphoma  2305.6 1720 3483 1542.3 1267 5030 - - - - 
 
- - - 
aProtocol DLP = DLP value for the protocol (Sum of DLP values in protocol where multiple sequences included). 
bPublished data references: Sudan - Suliman (2011)
15
; Tanzania - Ngaile (2006)
16
; Greece - Papadimitriou (2003)
17
, Italy - Origgi (2006)
18
. Dash (-) indicates no value reported. 
cNational DRL’s (Diagnostic Reference Levels) references: EU - European Commission 16262 (1999)
19
; UK - Shrimpton (2003)
12
; British columbia - Aldrich (2006)
20
; Canada - Health Canada (2008)
21




Table 4 Comparison of Effective doses for CT protocols performed in Western Australia for seven common clinical scenarios with published literature and international 
diagnostic reference levels 
 
Scan type/clinical scenario 



















Protocol Effective Dose (mSv)
a
                             
Head for Trauma or Stroke 3.61 3.4 4.5 0.9 2.4 4.6 1.6 2.1 2.1 1.7 2.4 1.5 2.8 - 
Chest for Lung Cancer 15.9 16 21 5.4 8.5 22.0 4.6 13 7.3 8 8.8 5.5 9 - 
Chest for Pulmonary Emboli 13.64 8.9 22 8.5 6.8 27.0 - - - - - - - - 
Chest for Diffuse Lung Disease 13.52 13 17.9 4.4 7.9 19.0 - - - - - - - - 
Abdomen for Liver Metastases 29.25 23 44.9 14.6 14.0 45.8 6.6 15 7.4 7.8 9 5.3 10.2 - 
Abdomen and Pelvis for Abscess 18.4 19.5 22.3 4.2 14.0 23.0 4 17 10.3 8.9 10.8 7.1 16.5 - 
Chest, Abdomen and Pelvis for Lymphoma  40 29.5 60.5 26.6 22.5 87.0 - - - - - - - - 
 
aProtocol DLP = DLP value for the protocol (Sum of DLP values in protocol where multiple sequences included). 
bPublished data references: Sudan - Suliman (2011)
15
; Tanzania - Ngaile (2006)
16
; Greece - Papadimitriou (2003)
17
, Italy - Origgi (2006)
18
. Dash (-) indicates no value reported. 
cNational DRL’s (Diagnostic Reference Levels) references: EU - European Commission 16262 (1999)
19
; UK - Shrimpton (2003)
12
; British columbia - Aldrich (2006)
20
; Canada - Health Canada (2008)
21
. Dash (-) indicates no 
value reported  
3.5. Demographic profile of CT scanning in Australia and Western Australia 
Figure 1 shows information about the volume of medical imaging and CT examinations conducted in 
Australia by State, across time and gender, funded under the Medicare Benefit Schedule (MBS) which 
is largely serviced by privately owned providers in the out-of-hospital setting. In WA, like other 
Australian States, CT scanning accounts for approximately 10% of medical imaging examinations 
(panel A). While this proportion remained relatively stable (panel C) the total number of CT 
examinations has increased by approximately 52% over the past 12 years (panel B) compared with a 
70% increase in medical imaging procedures as a whole. In this setting CT scanning is more often 
conducted on males than females (panel C).  
The trends are similar for hospitalised patients although, as shown in figure 2, the types of 
examinations conducted are different. In hospitalised patients (incorporating both private & public 
hospitals) the CT scanning scenarios included in our study accounted for the majority of CT 
performed (figure 2, panel A). Comparatively, in the MBS setting (largely out-of-hospital) CT 
scanning scenarios included in our study only accounted for approximately 50% of the CT scans 
undertaken. This demonstrates the significant difference in the clinical patient population of the two 
settings.  The age profile of patients undergoing CT examinations performed under the MBS (panel 
B) and in-hospital (panel C) is also slightly different, with the MBS setting having a slightly younger 
profile.  
Figure 1 Number and proportion of medical imaging and CT examinations conducted in Australia and Western Australia funded under the Medicare Benefits Scheme 
 
A: Number of procedures in 2010 by Australian State/Territory B: Number of procedures in Western Australia annually from 1999 to 2010
C: Proportion of medical imaging accounted for by CT scanning according to gender 1999 to 2010
Figure 2 Number (A) and proportion (B+C) of CT scans (all and selected in the study) performed (under the MBS and in hospitalised patients) in Western Australia 
 
C: Proportion of CT examinations performed in hospitalised patients in 2010 by age & genderB: Proportion of CT examinations performed under the MBS in 2010 by age & gender 
A: Number of CT scans performed (under the MBS and 
in hospitalised patients) in WA 1999-2010 
3.6. Ranking of clinical scenario by annual frequency and population effective dose 
Figure 3 shows the clinical scenarios included in the study ranked by contribution to the total number 
of CT scans performed (panel A) and the population annual effective dose using the median dose 
protocol (panel B) in WA 2005 to 2010.  Figure 3, panel B indicates that the total population annual 
effective dose received by the WA population rose from 1,006,581mSv in 2005 to 1,424,475mSv in 
2010, an increase of 42%. The increase shown is solely attributable to the increase in volume of CT 
scanning performed since no adjustment to the protocol doses was made across years. The figure 
shows that while Head CT is the most frequently performed (panel A) it does not account for the 
highest burden in effective dose, only contributing 127,040mSv to the total in 2010. Abdo/Pelvis CT 
accounts for the highest radiation burden (552,726mSv in 2010), being a relatively high dose protocol 
and having the second rank with regards to frequency. Of note Chest/Abdo/Pelvis CT while being 
relatively uncommon (rank 6 in frequency) is ranked second in contribution to the total population 
annual effective dose contributing 291,551mSv in 2010 due to its high dose.  
 
3.7. Potential change in population annual effective dose according to protocol used 
Figure 4 indicates the increase and decrease in the annual effective population dose achievable by 
consistently using the highest or lowest dose protocols observed in our study. Using this method an 
additional 865,006mSv (60%) would have been added to the annual population effective dose if the 
highest dose protocol had been utilised across all clinical scenarios in 2010. In contrast, if the lowest 
dose protocol observed were consistently utilised, a reduction of 460,421mSv (32%) could have been 
achieved. Figure 4 also indicates the influence the changes in the annual number of CT scans have 
had on the potential for increased and decreased population effective dose. The potential increase in 
effective dose by moving to the highest dose protocol has risen by 32% (287,279mSv) since 2005 due 
to the increase in frequency of CT scanning in these clinical scenarios. Conversely the potential 
reduction in the population effective dose has risen from 330,120mSv in 2005 to 460,421mSv in 
2010, affording an additional 28% (130,301mSv) potential reduction. 
Figure 3 CT scanning procedures selected in the study performed in Western Australia 2005-2010 ranked 





A: Number of selected CT scanning procedures performed in WA 2005-2010 
ranked by relative contribution to total number performed
 
B: Population annual effective dose (mSv) attributed to selected CT scanning 
procedures (based on median scenario) performed in Western Australia 2005-2010 
ranked by relative contribution to total effective dose




























































The current study has provided a snapshot of CT scanning practice in WA using previously validated 
and robust methods of data collection for dose assessment
22
. The results of this study are based on 
assessments for standard examinations which provide the basic framework for typical practice for any 
particular provider. The methods employed in data collection were previously validated by a study in 
the UK which showed doses to individual patients were similar on average to those for the 
corresponding standard protocol, and where there was significant variation it was largely due to 
additional sequences for further phases of contrast.
22
 Thus our study is likely to under rather than 
overestimate the upper limit of patient radiation dose. One limitation of our study is that it included 
only a limited sample of CT providers in WA and therefore may not be representative of all providers. 
This study demonstrates wide variations in technique and radiation dose across providers for similar 
examinations and the protocols reported by WA providers produce a higher radiation burden than 
reported in the international literature. Detailed information regarding patient numbers according to 
clinical scenario has allowed for the annual population cumulative effective doses to be calculated as 
well as the trends in the number of CT scans relative to the type of examination.  As expected the CT 
protocol used can dramatically affect the radiation dose received during a single CT examination and 
this has a significant effect on annual population doses which may in turn lead to significant changes 
in the likelihood of adverse biologic changes due to exposure to medical radiation.  
Medical applications of ionising radiation are accepted as essential tools for protecting and improving 
health
23
.  However, they also represent a significant source of radiation exposure to the population. 
The average effective background dose received by the Australian population is approximately 1.5 
mSv per year
24
.  Medical radiation, primarily from diagnostic imaging, has been estimated in 1999 to 
add an additional 50% (0.8 mSv) to the average population exposure
24
, with diagnostic imaging 
comprising 95% of man-made radiation exposure
9,25
.  In our study we recorded 1,424,475mSv (based 
on the median dose protocols reported) for the seven clinical scenarios investigated in a population of 
1,761,788 individuals aged 18+years
26
 which equates to an average population exposure of 0.81mSv 
attributable to the WA adult population in 2010 from the clinical CT scenarios included in our study. 
It should be recognised that while the clinical scenarios included in our study represented the majority 
(approximately 85%) of the CT examinations performed in hospitalised patients they only account for 
approximately 50% of the CT examinations undertaken in the out-of-hospital setting. Thus the 
average population exposure attributable to CT scanning in WA is likely to be far greater than 
estimated here and hence the dose attributable to medical imaging as a whole much greater than that 
reported in the literature. 
The world mean effective dose per examination and annual collective dose have increased in recent 
years
25
.  However, rather than averaging over the whole population, it is more relevant to compare 
typical medical radiation doses with the background radiation.  The UNSCEAR report
9
 showed that in 
developed countries, CT accounts for a few per cent of procedures but delivers almost one half of the 
radiation exposure from medical diagnosis. Hence CT represents the largest man-made source of 
exposure to ionising radiation with the average dose per examination six times higher than natural 
background
9
. Our data has a total dose of 1,420,000mSv in 105,000 procedures giving an average 
dose of 13.5mSv, which is almost 10 times the natural background in Australia. 
It is accepted by all international regulatory bodies that there is no threshold for the induction of 
cancer by ionising radiation and therefore it can be expected that diagnostic imaging procedures will 
induce some cancers
27
. Co-efficients for lifetime attributable risks of radiation induced cancer for a 
generalised population are that for every 1Sv of radiation dose received by the average person the risk 
of death will increase by 5%
28,29
. Note that this is a very crude approximation that allows a potential 
for reduced risk at low dose by reducing the risk by a Dose and Dose Rate Effectiveness Factor 
(DDREF) of 50%.  Since the magnitude of the difference in radiation dose between the lowest and 
highest protocol for some clinical scenarios in our study ranged from 50 to 60mSv, this would equate 
to a potential increase in the risk of death for an average person of 0.3%. Thus consensus between 
radiology providers on lowest clinically valid dosage protocols is crucial to reduce unnecessary 
exposure to radiation. 
Recognition of the variation in radiation dose across providers and comparison with other published 
surveys and national diagnostic reference levels is also required since our study has shown the 
radiation burden afforded by protocols in use in WA is higher by international standards. This result is 
not surprising given the results of the previous dose survey undertaken in 1996
10
 which also reported 
that Australian CT doses were higher by international standards. Our study confirms that this remains 
the case fourteen years later despite the publication of the earlier Australian study, increasing media 
attention regarding CT dosimetry and further development of dose reference levels internationally. 
Combined with the previous finding that Australia has a relatively high utilisation of CT scanning 
these data indicate an urgent need for dialogue in the Australian setting.  While the establishment of 
WA specific dose reference levels (DRLs) is the goal, it should be recognised the accepted method of 
their calculation (ie 75
th
 percentile of current doses) may not be appropriate without investigation of 
the context if the radiation dose appears higher than the norm internationally.   
 
4.1. Conclusion 
This study has provided a snapshot of CT scanning practice in Western Australia using previously 
validated robust methods of data collection for dose assessment. The study shows there are wide 
variations in technique and radiation dose across providers for similar examinations and that the 
protocols reported by Western Australian providers produce a higher radiation burden in an 
international context. The study highlights the need for recognition and understanding of both the 
degree of variation in radiation dose across providers and the relatively high radiation burden afforded 
by protocols in use in Western Australia so necessary dialogue can be launched for practitioner 
consensus of appropriate diagnostic reference levels in CT scanning. 
 
Acknowledgments 




1. Zweifel P, Ferrari M. Is there a Sisyphus Syndrome in health care? In: Zweifel P, Frech III H, 
editors. Health Economics Worldwide. Dordrecht, NL: Kluwer; 1992. 
2. Mayo JR, Aldrich J, Muller NL. Radiation exposure at chest CT: A statement of the 
Fleischner Society. Radiology 2003; 228 (1): 15-21. 
3. Weiner SN. Is medical radiation exposure a public health concern? The downside to 
technological advances in computed tomography. American Health Insurance Plans (AHIP) 
Coverage 2005; 46 (1): 52-55. 
4. Golding SJ, Shrimpton PC. Commentary: Radiation does in CT: are we meeting the 
challenge? The British Journal of Radiology 2002; 75: 1-4. 
5. Naik KS, Ness LM, Bowker AMB, Robinson PJA. Is computed tomography of the body 
overused? An audit of 2068 attendances in a large acute hospital. British Journal of Radiology 
1996; 69: 126-131. 
6. Shrimpton PC, Wall BF. The increasing importance of x-ray computed tomography as a 
source of medical exposure. Radiation Protection Dosimetry 1995; 57: 413-415. 
7. Wall BF. Implementation of DRLs in the UK. Radiation Protection Dosimetry 2005; 114 (1-
3): 183-187. 
8. Radiation Health Committee.(2005)  Summary of meeting held 9-10 March. Yallambie, 
Victoria: ARPANSA. 
9. United Nations Scientific Committee on the Effects of Atomic Radiation.(2000)  Sources and 
effects of ionizing radiation. New York: United Nations. 
10. Thomson JEM, Tingey DRC.(1997)  Radiation doses from computed tomography in 
Australia. Yallambie, Victoria: Australian Radiation Laboratory. 
11. OECD.(2011)  Health at a glance 2011: OECD Indicators: OECD Publishing. 
http://dx.doi.org/10.1787/health_glance-2011-en. 
12. Shrimpton PC, Hillier MC, Lewis MA, Dunn M.(2003)  Doses from Computed Tomography 
(CT) Examinations in the UK - NRPB-W67. Oxon: National Radiological Protection Board. 
13. Imaging and Performance and Assessment of CT scanners (ImPACT).(2001)  CT patient 
dosimetry Excel spreadsheet: Imaging and Performance and Assessment of CT scanners 
evaluation centre of the DH Medicines and Healthcare products Regulatory Agency (MHRA), 
http://www.impactscan.org. 
14. International Commission on Radiological Protection.(2007)  Recomendations of the 
International Commission on Radiological Protection  publication number 103: ICRP. 
15. Suliman II, Abdalla SE, Ahmed NA, Galal MA, Salih I. Survey of computed tomography 
technique and radiation dose in Sudanese hospitals. European Journal of Radiology 2011; 80: 
e544-e551. 
16. Ngaile JE, Msaki P, Kazema R. Towards establishment of the national reference dose levels 
from computed tomgraphy examinsations in Tanzania. Joournal of Radiological Protection 
2006; 26: 213-225. 
17. Papadimitriou D, Perris A, Manetou A, Molfetas M, Panagiotakis N, Lyra-Georgosopoulou 
M, et al. A survey of 14 computed tomography scanners in Greece and 32 scanners in Italy, 
examination frequencies, dose reference values, effective doses and doses to organs. 
Radiation Protection Dosimetry 2003; 104 (1): 47-53. 
18. Origgi D, Vigoritto S, Villa G, Bellomi M, Tosi G. Survey of computed tomography 
techniques and absorbed dose in Italian hospitals: a comparison between two methods to 
estimate the dose-length product and effective dose and to verify fulfilment of the diagnostic 
reference levels. European Journal of Radiology 2006; 16: 227-237. 
19. European Commission.(1999)  European guidelines on quality criteria for computed 
tomography. EUR 16262 EN. Luxenburg: Office for Official Publications of the European 
Communities. 
20. Aldrich JE, Bilawich A, Mayo JR. Radiation dose to patients receiving computed tomography 
examinations in British Columbia. Canadian Association of Radiology Journal 2006; 57 (2): 
79-85. 
21. Health Canada.(2008)  Safety Code 35: Safety procedures for the installation use and control 
of X-ray equipment in large medical radiological facilities: Section A: 3.5. Ottawa, Ontario: 
Health Canada. 
22. Shrimpton PC, Hillier MC, Lewis MA, Dunn M. National survey of doses from CT in the 
UK:2003. The British Journal of Radiology 2006; 79: 968-980. 
23. Regulla DF, Eder H. Patient exposure in medical x-ray imaging in Europe. Radiation 
Protection Dosimetry 2005; 114 (1-3): 11-25. 
24. Webb DV, Solomon SB, Thomson JEM. Background radiation levels and medical exposure 
levels in Australia. Radiation Protection In Australasia 1999; 16 (1). 
25. Ron E. Cancer risks from medical radiation. Health Physics 2003; 85 (1): 47-59. 
26. Australian Bureau of Statistics.(2012)  3101.0 - Australian Demographic Statistics, Dec 2011. 
Estimated resident population by single year of age 1971-2011 in Western Australia, . 
Canberra: ABS. 
27. Baerlocher M. O., Detsky A. S. Discussing Radiation Risks Associated With CT Scans With 
Patients. JAMA (Chicago, Ill.) 2010; 304 (19): 2170-2171. 
28. Catuzzo P, Aimonetto S, Zenone F, Fanelli G, Marchisio P, Meloni T, et al. Population 
exposure to ionising radiation from CT examinations in Aosta Valley between 2001 and 
2008. The British Journal of Radiology 2010; 83: 1042-1051. 
29. United Kingdom Health Protection Agency. Understanding Radiation Available at: 
http://www.hpa.org.uk/, Accessed 2012. 
 
 
